Roche with­draws Tecen­triq in blad­der can­cer amid FDA's sweep­ing re­view on ac­cel­er­at­ed ap­provals

The “in­dus­try-wide re­view of ac­cel­er­at­ed ap­provals” that’s been mak­ing waves in the check­point field has reached Roche.

With prod­ding from the FDA, the Swiss phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER